Klinik und Poliklinik für Diagnostische und Interventionelle Radiologie
Klinikum / Johannes Gutenberg-Universität Mainz
Forschungsprojekte
Ergebnisse pro Seite:
50
2024 - 2022
A Randomized Open Label Phase 1/2 Study of INCB001158 Combined With Subcutaneous (SC) Daratumumab, Compared To Daratumumab SC, in Participants With Relapsed or Refractory Multiple Myeloma- Dr. med. Markus Munder,
- Prof. Dr. med. Georg Heß
2023 - 2030
Early treatment intensification in patients with high risk Mantle Cell Lymphoma using CAR-T-cell treatment after an abbreviated induction therapy with Rituximab and Ibrutinib and 6 months Ibrutinib maintenance (Arm A) as compared to standard of care induction and maintenance (Arm B)- Prof. Dr. med. Georg Heß
2023 - 2026
A Phase II, Multicenter, Randomized, Double-Blind Study of Tobemstomig/RO7247669 Combined With Nab-Paclitaxel Compared With Pembrolizumab Combined With Nab-Paclitaxel in Participants With Previously Untreated, PD-L1-Positive, Locally-Advanced Unresectable or Metastatic Triple-Negative Breast Cancer- Univ.-Prof. Dr. med. Marcus Schmidt,
- Dr. Katrin Almstedt
2022 - 2026
A Phase III Randomized, Open-Label, Multicenter Study to Determine the Efficacy and Safety of Durvalumab in Combination With Tremelimumab and Enfortumab Vedotin or Durvalumab in Combination With Enfortumab Vedotin for Perioperative Treatment in Patients Ineligible for Cisplatin or Who Refuse Cisplatin Undergoing Radical Cystectomy for Muscle InvasiveBladder Cancer (VOLGA)- PD Dr. med. Maximilian Brandt,
- PD Dr. Rene Mager,
- Dr. Anita Thomas
2021 - 2030
TEDOVA Randomisierte Phase II Studie zum Vergleich eines neo-epitope basierten Vakzin OSE2101 (TEDOPI®) +/- anti-PD1 (Pembrolizumab) versus supportiver Therapie/Beobachtung in der Erhaltungstherapie bei Patientinnen mit platin-sensitiven Ovarialkarzinom-Rezidiv und kontrollierter Erkrankung nach platinbasierter Chemotherapie.- Dr. Anne-Sophie Heimes,
- Univ.-Prof. Dr. Annette Hasenburg
2021 - 2026
A Phase 3 Open-Label, Randomized Study of LOXO-305 versus Investigator Choice of BTK Inhibitor in Patients with Previously Treated BTK Inhibitor Naïve Mantle Cell Lymphoma (BRUIN-MCL-321) (#1349)- Prof. Dr. med. Georg Heß,
- Marie-Kristin Tilch
2021 - 2027
A Phase 1/2a First-in-human Study to Evaluate the Safety, Tolerability and Efficacy of IMA401, a bispecific T cell engaging receptor molecule (TCER®) in patients with recurrent and/or refractory solid tumors.- Marius Fried,
- Dr. med. Alexander Desuki
2021 - 2027
Pre-Screening for A Phase Ia/Ib first-in-human clinical trial to evaluate the safety, tolerability and Initial anti-tumor activity of IMA401, a bispecific T cell engaging receptor molecule (TCER®), in patients with recurrent and/or refractory solid tumors- Marius Fried,
- Dr. med. Alexander Desuki
2020 - 2021
RACOON- “Radiological COOperative Network zur COVID-19 Pandemie“- Univ.-Prof. Dr. Christoph Düber,
- PD Dr. Roman Klöckner,
- Dr. Simin Schadmand-Fischer
2019 - 2023
Statische und dynamische Wirbelsäulenvermessung mittels DIERS 4D motion® Lab bei Thoraxwanddeformitäten- Stephan Rohleder,
- Dr. Ulrich Betz,
- Dr. André Lollert
2018 - 2020
INCB 54828-201: A Phase 2, Open-label, Single Agent, Multi-Center Study to Evaluate the Efficacy and Safety of a Pan-FGFR Tyrosine Kinase Inhibitor INCB054828 in Patients with Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations- Prof. Dr. Igor Tsaur,
- PD Dr. Thomas Höfner,
- PD Dr. Wolfgang Jäger
2018 - 2019
FORT-1:Phase 2/3 study of rogaratinib (BAY 1163877) vs chemotherapy in patients with FGFR-positive locally advanced or metastatic urothelial carcinoma- Prof. Dr. Georg Bartsch,
- Prof. Dr. Igor Tsaur,
- PD Dr. Thomas Höfner
2018 - 2022
FORT-2: Phase 1b/2 study of rogaratinib (BAY 1163877) in combination with atezolizumab in urothelial carcinoma- Prof. Dr. Georg Bartsch,
- Prof. Dr. Igor Tsaur,
- PD Dr. Thomas Höfner
2018 - 2019
EUCLID - European Study on Clinicat Diagnostic Reference Levels for X-ray Medical lmaging- Prof. Dr. Peter Mildenberger
2017 - 2022
TIPS bei Kandidaten zur Lebertransplantation: Auswirkung des TIPS auf Überlebenszeit, Quality-of-Life und Komplikationen während der Wartezeit auf die Lebertransplantation. Klinische Studie, monozentrisch, matched pair-Vergleichsstudie- PD Dr. Tim Zimmermann,
- Prof. Dr. Michael B. Pitton
2017 - 2019
Untersuchung der Ergebnisse nach TIPS-Anlage wegen therapierefraktärem Aszites und Ösophagusvarizenblutungen. Klinische Studie, monozentrisch, retrospektiv- Prof. Dr. Michael B. Pitton,
- PD Dr. Tim Zimmermann,
- Dr. Maria Hoppe-Lotichius
2017 - 2019
Myocardial Texture Analysis in healthy volunteers and cardiomyopathies- Dr. Tilman Emrich
2017 - 2021
MEDIRAD - Implications of Medical Low Dose Radiation Exposure- Prof. Dr. Peter Mildenberger
2016 - 2019
Irreversible electroporation: Correlation of necrosis in MRI and ultrasound using an animal model- Dr. Sebastian Schotten,
- Dr. Florian Jungmann,
- Prof. Dr. Michael B. Pitton
2016 - 2019
Klinisch-onkologische Effektivität der Irreversiblen Elektroporation (IRE) zur Behandlung solider Tumore. Klinische Studie, monozentrisch, prospektiv- Prof. Dr. Michael B. Pitton,
- Dr. Sebastian Schotten
2016 - 2019
SIRT versus TACE bei CCC: Klinisch-onkologische Effektivität der SIRT (Selective Internal Radia-tion Therapy) und der TACE (Transarterial Chemoembolisation) zur Behandlung des intrahepati-schen Cholangiozellulären Karzinoms (CCC). Klinische Studie, monozentrisch, prospektiv, randomisiert.- Prof. Dr. Michael B. Pitton,
- PD Dr. Roman Klöckner,
- Dr. Sebastian Schotten
2016 - 2019
Analyse des Aufgabenstellungen und der Interventionen im Rahmen der Lebertransplantation. Klinische Studie, monozentrisch, retrospektiv- Prof. Dr. Michael B. Pitton,
- PD Dr. Tim Zimmermann,
- PD Dr. Arndt Weinmann,
- Dr. Maria Hoppe-Lotichius,
- Dr. Jens Mittler
2016 - 2017
Zeitlicher Verlauf der Gewebeschädigung nach IRE an Leber und Niere im Tiermodell- Dr. Sebastian Schotten,
- Dr. Florian Jungmann,
- Prof. Dr. Michael B. Pitton
2016 - 2018
Beurteilung von Muskelverletzungen bei Leistungssportlern mit der MR-Tomographie- Prof. Dr. Karl-Friedrich Kreitner
2016 - 2018
CT for planning and follow-up in percutaneous mitral- and tricuspidal valve repair- Dr. Tilman Emrich
2016 - 2019
Predictive scoring systems for patients with hepatocellular carcinoma- PD Dr. Roman Kloeckner
2015 - 2016
Iterative Reconstruction in computer tomography before TAVI : qualitative and quantitative evaluation of image quality- Prof. Dr. Karl-Friedrich Kreitner,
- Dr. Yang Yang
2015 - 2017
Mapping of myocardial T1- an T2-relaxation times in 3 Tesla-MRI- Prof. Dr. Karl-Friedrich Kreitner,
- Dr. Tilman Emrich
2014 - 2016
Assessment of Aortic Annulus Size at MD-CT: Influence of Heart Phase and Measurement Method in Patients before TAVI- Prof. Dr. Karl-Friedrich Kreitner,
- Dr. Yang Yang
2014 - 2016
Prognostischer Wert der kardialen Magnetresonanztomographie bei Patienten mit akuten Brustschmerzen, erhöhten kardialen Enzymen und unauffälliger Koronarangiographie- Prof. Dr. Karl-Friedrich Kreitner,
- Dr. Tilman Emrich
2013 - 2014
Pretherapeutic MR-imaging of pectus excavatum and pectus carinatum chest wall- Univ.-Prof. Dr. Gundula Staatz
2013 - 2014
Evaluation of thyroid diseases in pediatric oncological patients after treatment with a high dosage of chemotherapy and/or radiation therapy of the head and neck- Univ.-Prof. Dr. Gundula Staatz
2013 - 2015
Hochkanalspulen für die Magnetresonanztomographie (BMBF)- Univ.-Prof. Dr. Laura Schreiber